Suppr超能文献

来曲唑与促性腺激素用于克罗米芬治疗未孕患者促排卵的比较。

A comparison of letrozole to gonadotropins for ovulation induction, in subjects who failed to conceive with clomiphene citrate.

作者信息

Quintero Rudolfo B, Urban Renata, Lathi Ruth B, Westphal Lynn M, Dahan Michael H

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA 94305-5317, USA.

出版信息

Fertil Steril. 2007 Oct;88(4):879-85. doi: 10.1016/j.fertnstert.2006.11.166.

Abstract

OBJECTIVE

To compare pregnancy rates (PR) for letrozole and gonadotropins in individuals who failed to conceive with clomiphene citrate (CC).

DESIGN

Retrospective cohort study.

SETTING

University reproductive center.

PATIENT(S): Individuals treated with letrozole or gonadotropins who failed to conceive with CC.

INTERVENTION(S): Controlled ovarian hyperstimulation (COH), transvaginal ultrasound, ovulation induction, IUI.

MAIN OUTCOME MEASURE(S): Pregnancy rates per cycle.

RESULT(S): Among patients who failed to conceive with at least three cycles of CC, gonadotropins had a higher PR per cycle than letrozole. Among individuals who failed to conceive with less than three cycles of CC and whose medications were changed because of thin uterine lining or intolerable side effects, average PR per cycle for letrozole and gonadotropin treatments were equivalent. All patients conceived within three stimulation cycles with either gonadotropins or letrozole.

CONCLUSION(S): In patients who failed to conceive with CC, gonadotropins have higher PR for ovulation induction than letrozole. However, PR were high enough with letrozole to justify its use in this population of patients. Letrozole and gonadotropins should not be used for more than three cycles without a conception.

摘要

目的

比较来曲唑和促性腺激素对枸橼酸氯米芬(CC)治疗后仍未受孕者的妊娠率(PR)。

设计

回顾性队列研究。

地点

大学生殖中心。

患者

接受来曲唑或促性腺激素治疗且CC治疗未受孕者。

干预措施

控制性卵巢刺激(COH)、经阴道超声检查、排卵诱导、宫腔内人工授精(IUI)。

主要观察指标

每个周期的妊娠率。

结果

在至少三个周期CC治疗仍未受孕的患者中,促性腺激素每个周期的PR高于来曲唑。在CC治疗少于三个周期且因子宫内膜薄或无法耐受副作用而更换药物的患者中,来曲唑和促性腺激素治疗的平均每个周期PR相当。所有患者使用促性腺激素或来曲唑在三个刺激周期内均受孕。

结论

在CC治疗未受孕的患者中,促性腺激素诱导排卵的PR高于来曲唑。然而,来曲唑的PR足够高,足以证明其在这类患者中的应用合理性。来曲唑和促性腺激素在未受孕的情况下使用不应超过三个周期。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验